Apomivir for treating flu symptoms
Part of Ear, nose & throat, Infections, Lungs & breathing, Mouth & dental clinical trials.
This study tests a new medicine called Apomivir to see if it safely and effectively treats flu symptoms. It may help you recover faster if you have the flu.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 65 years old.
- You have had flu-like symptoms for less than 48 hours, such as cough, sore throat, or stuffy nose, plus at least one other symptom like headache, tiredness, or muscle aches.
- A rapid test confirms you have influenza A or B.
- You are not pregnant, breastfeeding, or planning to become pregnant, and if you could become pregnant, you agree to use a reliable birth control method.
- You do not have serious lung disease, severe breathing problems, or other major health conditions that could make participation risky.
- You have not taken blue agar supplements or any investigational drugs recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
This study tests an experimental antiviral pill called Onradivir for teenagers (ages 12 to 17) with uncomplicated influenza A. It aims to see if the drug can safely shorten flu symptoms and help you recover faster.
This study tests an experimental medicine called TRX-100 to see if it can safely treat the flu. Healthy volunteers will be given the flu virus in a controlled setting, then the medicine, to see how well it works.
This trial tests an oral tablet (SYH2085) to see if it can help adults with the flu feel better faster. If you join, you'll either get the study drug or a placebo (a pill with no medicine).
This study compares two versions of an antiviral medicine called Ingavirin to see how your body processes them and whether they are safe. Researchers will give you the medicine on an empty stomach and after eating to understand how food affects how your body absorbs it.
This study tests a new type of flu prevention medicine (called a monoclonal antibody) given as an injection. It is for people at higher risk of getting the flu, including those with certain health conditions or weakened immune systems.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.